<DOC>
	<DOCNO>NCT02305459</DOCNO>
	<brief_summary>The administration SIR-Spheres microspheres ( yttrium-90 resin microspheres ) form selective internal radiation therapy ( SIRT ) treatment patient primary secondary liver tumour . The CIRT Registry two major objective : 1 ) To collect robust data real-life clinical practice radioembolisation SIR-Spheres microspheres pan-European context , 2 ) collect data Quality Life patient treat SIR-Spheres microspheres .</brief_summary>
	<brief_title>CIRSE Registry SIR-Spheres Therapy</brief_title>
	<detailed_description>Selective internal radiation therapy ( SIRT ) , also call radioembolisation ( RE ) , SIR-Spheres microspheres endovascular procedure , include within interventional oncologic technology treat primary secondary liver tumour . Using microcatheter , precise dose resin microspheres release hepatic artery , carry arteriole selectively lodge tumour microvasculature . The microspheres load radioactive yttrium-90 , high-energy beta-emitting isotope half-life 64.1 hour . Following administration , 94 % radiation deliver 11 day . Previous report safety efficacy yttrium-90 resin microspheres treatment primary secondary liver tumour promise . In order improve understanding therapy true clinical setting , Cardiovascular Interventional Radiological Society Europe ( CIRSE ) initiate CIRSE Registry SIR-Spheres Therapy ( CIRT ) , phase 4 observational study aim collect robust data real-life clinical practice radioembolisation SIR-Spheres microspheres . Further , use quality life questionnaire QLQ-C30 hepatocellular carcinoma module ( develop verify European Organisation Research Treatment Cancer ( EORTC ) ) , CIRT aim collect data quality life patient treat SIR-Spheres microspheres .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Treatment liver tumour SIRspheres microspheres Primary secondary liver tumour Signed informed consent form 18 year old Exclusion criterion Under 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>SIRT</keyword>
	<keyword>microcatheter</keyword>
	<keyword>primary liver tumor</keyword>
	<keyword>secondary liver tumor</keyword>
	<keyword>radioembolisation</keyword>
	<keyword>QLQ-C30</keyword>
	<keyword>CIRSE</keyword>
</DOC>